Bupa

Private medical Insurers (PMI) have endorsed the Office of Fair Trading referring the UK healthcare market to the Competition Commission and said they will take an active part in investigations.

Bupa has revealed the first results statistics on its controversial open referral initiative, and the results are encouraging according to the insurer.

A significant proportion of the UK's small business bosses are risking their health as they battle absence to keep businesses afloat, according to Bupa.

Questions have been tabled in the House of Lords' asking the government for its assessment of key elements of the private medical insurance (PMI) market.

Bupa has become the second insurer to give further clarity about its complaints levels, suggesting providers may want further details to be published by the Ombudsman to put figures into a wider context.

The private medical insurance (PMI) market's two biggest players have seen a rise in the number of complaints escalated to the Financial Ombudsman Service (FOS).

It is clear that medical inflation is having consequences, but what is causing it and what is to be done? Mike Izzard investigates.

Axa PPP has extended its cancer coverage to include the clinically effective prostate cancer drug rejected for the NHS because it is too expensive.

The coming year promises to be a tough one for the private healthcare sector, according to a new report from analyst Laing and Buisson.

Healix has voiced support for the use of open referrals within the private medical insurance (PMI) market but warned that insurers need to be more transparent about the process.